Skip to main content
OpenTrials
Completed

NCT Number: NCT07023042

Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites

The goal of this clinical trial is to find out whether abdominal Kinesio-taping is a feasible and effective way to relieve symptoms in patients with malignant bowel obstruction and ascites who still have severe symptoms after surgery, medication, or nasogastric tube treatment.

The main questions it aims to answer are:

* Can abdominal Kinesio-taping reduce the severity of symptoms, such as abdominal pain, bloating, and nausea, in these patients? * Is abdominal Kinesio-taping a safe and practical treatment option for this patient group?

Participants in this study are adults with cancer who have been diagnosed with malignant bowel obstruction and ascites, and whose symptoms have not improved after standard medical treatments. People who are allergic to tape, have abdominal wounds, are pregnant, or are unable to provide consent will not be included.

Participants will be randomly assigned to one of two groups:

* The Kinesio-taping group will receive standard care for malignant bowel obstruction plus abdominal Kinesio-taping, applied by trained professionals using a standardized procedure. * The control group will receive standard care only.

The main outcomes measured will be changes in symptom severity using the Edmonton Symptom Assessment System (ESAS) modified for ascites, as well as abdominal girth and pain medication use. Symptoms and side effects will be closely monitored to ensure safety.

The information from this study may help determine whether Kinesio-taping can be an additional, safe, and effective option for managing symptoms in patients with advanced cancer who have malignant bowel obstruction and ascites.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Taiwan University Hospital

Taipei, 100225, Taiwan

About this study

Malignant bowel obstruction (MBO) with ascites is a common and severe complication among patients with advanced intra-abdominal or retroperitoneal malignancies. Standard management of MBO includes surgery, medical therapy (such as antiemetics, corticosteroids, or octreotide), and decompression using nasogastric tubes. However, many patients continue to experience distressing symptoms-such as persistent abdominal pain, nausea, vomiting, and bloating-despite aggressive treatment. These symptoms contribute to significant discomfort, reduced quality of life, and poor prognosis in patients with advanced cancer.

Kinesio-taping is an elastic, waterproof adhesive strip designed to mimic the properties of skin and soft tissue. It is widely used in rehabilitation and sports medicine for its potential to reduce pain, improve circulation, and provide mechanical support. The mechanism is thought to involve stimulation of cutaneous mechanoreceptors, improved lymphatic drainage, and modulation of muscle activity. While Kinesio-taping has shown benefits in managing lymphedema and musculoskeletal pain, its application in patients with MBO and ascites is not well-studied. Existing evidence is mostly limited to case reports and studies in other patient populations.

This randomized controlled trial aims to evaluate whether abdominal Kinesio-taping, in addition to standard care, can safely and effectively reduce symptom burden in adult cancer patients with MBO and ascites whose symptoms persist after conventional treatment. The trial is conducted at a single tertiary medical center. Eligible patients are randomized in a 1:1 ratio to either the intervention group (standard care plus Kinesio-taping) or the control group (standard care alone). The Kinesio-taping protocol uses an FDA-approved medical-grade tape (NKH-50R) and follows a standardized application technique. Prior to the first application, all patients in the intervention group undergo a skin sensitivity test. The tape is applied in a circular pattern around the umbilicus, with specific attention to avoiding tumor sites and open wounds, and removed using techniques designed to minimize skin trauma.

All participants continue to receive standard care for MBO, including pain management, fluid and electrolyte support, and palliative interventions as appropriate. Data are collected at baseline and three days after intervention. The primary outcome is change in symptom severity, measured by the Edmonton Symptom Assessment System modified for ascites (ESAS:AM). Secondary outcomes include changes in abdominal girth and dosage of analgesic medications. Safety is monitored through daily assessment for skin reactions or other adverse effects.

This study is designed with rigorous attention to ethical conduct and data privacy. All participant information is de-identified and securely stored, and only authorized research personnel have access. The anticipated sample size is 40 participants, with randomization stratified by baseline symptom severity to ensure balanced allocation. Data will be analyzed using appropriate statistical methods, including independent t-tests and generalized estimating equations for repeated measures.

If proven effective and safe, Kinesio-taping could offer a non-invasive, low-cost, and easily administered adjunct to standard palliative care for patients with malignant bowel obstruction and ascites, potentially empowering both patients and caregivers with a new option for symptom relief.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older.
  • Histologically confirmed intra-abdominal or retroperitoneal malignancy.
  • Diagnosis of malignant bowel obstruction with ascites located below the ligament of Treitz.
  • Persistent severe symptoms (such as pain, bloating, nausea, vomiting) after surgery, medication, or nasogastric tube treatment.
  • Able to communicate in Mandarin or Taiwanese.
  • Capable of providing informed consent.

Exclusion criteria

  • Presence of significant abdominal wounds that preclude application of Kinesio tape.
  • Known allergy or hypersensitivity to Kinesio tape.
  • Pregnancy.
  • Lack of decision-making capacity.

Treatment and study plan

Abdominal Kinesio Taping

Other

Application of medical-grade Kinesio tape (NKH-50R) to the abdomen using a standardized circular technique, in addition to standard care for malignant bowel obstruction and ascites. Tape is applied by trained professionals after a skin sensitivity test and changed every three days or as needed. The procedure avoids open wounds and tumor sites. Participants and caregivers are educated on tape care and removal.

Other names: Kinesio taping, KT, Kinesiotaping, Kinesiology taping, Kinesiology tape, K-active tape

Standard Care Arm

Other

Standard palliative care for malignant bowel obstruction and ascites, including symptom management, nutritional support, and medical treatment according to institutional protocols.

Primary outcomes

  1. Change in symptom severity score using the Edmonton Symptom Assessment System-Ascites Modification (ESAS:AM)

    Time frame: Baseline and 3 days after intervention

    Symptom severity will be measured using the ESAS:AM, which includes 11 items evaluating abdominal pain, bloating, nausea, and other symptoms related to malignant bowel obstruction and ascites. Each item is scored on an 11-point numeric rating scale (0-10), and the average score will be used for analysis. The primary outcome is the change in average symptom severity score from baseline to Day 3 after intervention.

Secondary outcomes

  1. Change in abdominal girth

    Time frame: Baseline and 3 days after intervention

    Abdominal circumference will be measured in centimeters at the level of the umbilicus using a standard measuring tape. The primary comparison is the change in abdominal girth from baseline to Day 3 after intervention.

  2. Change in analgesic medication use

    Time frame: Baseline and 3 days after intervention

    The total dose of analgesic medications (including morphine, fentanyl, oxycodone, and corticosteroids) administered to each participant will be recorded. The outcome is the change in total analgesic dose from baseline to Day 3 after intervention.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Treatment of Kinesio-taping Versus Usual Care for Patients of Malignant Bowel Obstruction and Ascites With Persistent Severe Symptoms After Surgery, Medication and Nasogastric Tube: a Randomized Controlled Trial

Acronym: KTMBO-RCT

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 15, 2025
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.